Phase 2 Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Women aged 18 to 75 years who have not yet received any treatment for breast cancer
- People with a confirmed diagnosis of early or locally advanced triple-negative breast cancer (a specific type where the cancer tests negative for oestrogen receptors, progesterone receptors, and HER2), confirmed through a tissue sample analysis
- People with stage II or III invasive breast cancer that has at least one measurable tumour
- People with a good general health and activity level (rated 0 or 1 on a standard health scale used in clinical trials)
- People assessed by a radiation specialist as able to safely receive radiotherapy before and after surgery
- People with adequate organ function (confirm with trial site for specific requirements)
- People who are willing to participate, have signed a consent form, and are expected to follow the study requirements
Who may not be able to join:
- People whose breast cancer has spread to other parts of the body, or who have cancer in both breasts
- People with inflammatory breast cancer or a type of breast cancer with no detectable primary tumour in the breast
- People who have received any cancer treatment in the 12 months before joining the trial, including chemotherapy, targeted therapy, radiotherapy, hormone therapy, immunotherapy, biological therapy, or tumour embolisation
- People who have previously been treated with certain immune checkpoint drugs, including PD-1, PD-L1, or CTLA-4 blocking treatments
- People who are pregnant, breastfeeding, have a positive pregnancy test at the start of the trial, or are of childbearing age and are unwilling to use effective contraception throughout the trial
- People with a known history of neurological or psychiatric conditions such as epilepsy or dementia, or a known history of alcohol dependence or misuse of mind-altering substances
- People with HIV, AIDS, or certain active viral hepatitis infections (including hepatitis B or hepatitis C, confirmed through specific blood tests)
- People who, in the opinion of the trial investigators, have any other condition that makes participation unsuitable
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 18940254967
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
tpCR
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.